N-(2-Chloro-6-methylphenyl)-N-4-pyridinylurea
CAS No. 97627-24-2
N-(2-Chloro-6-methylphenyl)-N-4-pyridinylurea ( —— )
产品货号. M26317 CAS No. 97627-24-2
N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea is an anticonvulsant agent, treatment of generalized tonic-clonic and partial seizures.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1320 | 有现货 |
|
10MG | ¥2252 | 有现货 |
|
25MG | ¥4463 | 有现货 |
|
50MG | ¥6423 | 有现货 |
|
100MG | ¥8829 | 有现货 |
|
500MG | ¥17739 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称N-(2-Chloro-6-methylphenyl)-N-4-pyridinylurea
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea is an anticonvulsant agent, treatment of generalized tonic-clonic and partial seizures.
-
产品描述N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea is an anticonvulsant agent, treatment of generalized tonic-clonic and partial seizures.(In Vivo):N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea shows anticonvulsant activity at 30 mg/kg in the initial tests with no signs of ataxia until 300 mg/kg.?The activity seen with 30 mg/kg 37 is still present 4 h postdose.?Compound is effective against seizures induced by maximal electroshock but does not protect mice from clonic seizures produced by the convulsant pentylenetetrazol.?The overall pharmacological profile suggests that Compound would be of therapeutic use in the treatment of generalized tonic-clonic and partial seizures.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体nAChR; PAFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number97627-24-2
-
分子量261.7
-
分子式C13H12ClN3O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCc1cccc(Cl)c1NC(=O)Nc1ccncc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Synthesis and anti-platelet activity of ferulamide derivativesJournal of Chinese Pharmaceutical Sciences, 2002, 54(1):41-52.
产品手册
关联产品
-
Tigloylgomisin O
Tigloylgomisin O is a natural product for research related to life sciences.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
-
FEN1 Inhibitor C2
FEN1-IN-4 is an inhibitor of human flap endonuclease-1 (hFEN1)FEN1 Inhibitor C2 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a, both frequently mutated in colorectal cancers.?